Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
NCT ID:
NCT04033432
Recruitment Details:
The first patient started treatment on 10/01/2019. The study was designated to enroll patients s with mCRPC who have progressive disease despite castrate levels of testosterone (\<50 ng/dL) and have received at least one standard first-line therapy for metastatic castrate resistant prostate cancer, which can include therapy with a 2 nd generation AR targeted therapy (abiraterone or enzalutamide) or chemotherapy (docetaxel or cabazitaxel).The study was closed to further enrollment on 04/07/2021.
Study:
NCT04033432
Study Brief:
Results Section:
NCT04033432